Works matching IS 00099236 AND DT 2005 AND VI 77 AND IP 1
Results: 9
Effect of tadalafil on cytochrome P450 3A4—mediated clearance: Studies in vitro and in vivo.
- Published in:
- Clinical Pharmacology & Therapeutics, 2005, v. 77, n. 1, p. 63, doi. 10.1016/j.clpt.2004.09.006
- By:
- Publication type:
- Article
Marked effect of liver and kidney function on the pharmacokinetics of selegiline.
- Published in:
- Clinical Pharmacology & Therapeutics, 2005, v. 77, n. 1, p. 54, doi. 10.1016/j.clpt.2004.09.004
- By:
- Publication type:
- Article
Neurocognitive changes in patients with hepatitis C receiving interferon alfa-2b and ribavirin.
- Published in:
- Clinical Pharmacology & Therapeutics, 2005, v. 77, n. 1, p. 90, doi. 10.1016/j.clpt.2004.09.007
- By:
- Publication type:
- Article
Population pharmacokinetics of CCI-779: Correlations to safety and pharmacogenomic responses in patients with advanced renal cancer.
- Published in:
- Clinical Pharmacology & Therapeutics, 2005, v. 77, n. 1, p. 76, doi. 10.1016/j.clpt.2004.08.025
- By:
- Publication type:
- Article
Relationship of systemic exposure to unbound docetaxel and neutropenia.
- Published in:
- Clinical Pharmacology & Therapeutics, 2005, v. 77, n. 1, p. 43, doi. 10.1016/j.clpt.2004.09.005
- By:
- Publication type:
- Article
Hepatic technetium Tc 99m-labeled sestamibi elimination rate and ABCB1 (MDR1) genotype as indicators of ABCB1 (P-glycoprotein) activity in patients with cancer.
- Published in:
- Clinical Pharmacology & Therapeutics, 2005, v. 77, n. 1, p. 33, doi. 10.1016/j.clpt.2004.09.002
- By:
- Publication type:
- Article
P-glycoprotein and surfactants: Effect on intestinal talinolol absorption.
- Published in:
- Clinical Pharmacology & Therapeutics, 2005, v. 77, n. 1, p. 24, doi. 10.1016/j.clpt.2004.09.001
- By:
- Publication type:
- Article
Different effects of three transporting inhibitors, verapamil, cimetidine, and probenecid, on fexofenadine pharmacokinetics.
- Published in:
- Clinical Pharmacology & Therapeutics, 2005, v. 77, n. 1, p. 17, doi. 10.1016/j.clpt.2004.08.026
- By:
- Publication type:
- Article
Clinical consequences of cytochrome P450 2C9 polymorphisms.
- Published in:
- Clinical Pharmacology & Therapeutics, 2005, v. 77, n. 1, p. 1, doi. 10.1016/j.clpt.2004.08.009
- By:
- Publication type:
- Article